[Epidemiology of age-related macular degeneration. Situation in Spain].
作者信息
Damián Javier, Pastor Roberto, Armadá Félix, Arias Luis
机构信息
Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Madrid. España.
出版信息
Aten Primaria. 2006 Jun 15;38(1):51-7. doi: 10.1157/13090016.
Abstract
摘要
相似文献
1
[Epidemiology of age-related macular degeneration. Situation in Spain].[年龄相关性黄斑变性的流行病学。西班牙的情况]
Aten Primaria. 2006 Jun 15;38(1):51-7. doi: 10.1157/13090016.
2
Prevalence of age-related macular degeneration in Thailand.泰国年龄相关性黄斑变性的患病率。
Ophthalmic Epidemiol. 2011 Feb;18(1):48-52. doi: 10.3109/09286586.2010.545502.
3
[Age related macular degeneration].年龄相关性黄斑变性
Duodecim. 2005;121(14):1533-40.
4
Photodynamic therapy for age-related macular degeneration treatment: epidemiological and clinical analysis of a long-term study.光动力疗法治疗年龄相关性黄斑变性：一项长期研究的流行病学和临床分析
Ophthalmic Surg Lasers Imaging. 2009 May-Jun;40(3):277-84. doi: 10.3928/15428877-20090430-09.
5
Age-Related Macular Degeneration.年龄相关性黄斑变性
Prim Care. 2015 Sep;42(3):377-91. doi: 10.1016/j.pop.2015.05.009.
6
The epidemiology of age-related macular degeneration.
Int Ophthalmol Clin. 2004 Fall;44(4):17-39. doi: 10.1097/00004397-200404440-00004.
7
Association between psoriasis and neovascular age-related macular degeneration: A population-based study.银屑病与新生血管性年龄相关性黄斑变性之间的关联：一项基于人群的研究。
J Am Acad Dermatol. 2015 Jun;72(6):1090-2. doi: 10.1016/j.jaad.2015.03.002.
8
[Age-related macular degeneration (AMD)--primary results "Bus-Tour'2011" action].
Klin Oczna. 2011;113(10-12):341-5.
9
Age-related macular degeneration.年龄相关性黄斑变性
Postgrad Med J. 1998 Apr;74(870):203-7. doi: 10.1136/pgmj.74.870.203.
10
[2/6--Age-related macular degeneration].[2/6 - 年龄相关性黄斑变性]
Soins Gerontol. 2009 Mar-Apr(76):45-6.
引用本文的文献
1
[Determinants of access to dental health in Spain].[西班牙口腔健康可及性的决定因素]
Aten Primaria. 2025 Jun 17;57(10):103264. doi: 10.1016/j.aprim.2025.103264.
2
Novel Treatments for Age-Related Macular Degeneration: A Review of Clinical Advances in Sustained Drug Delivery Systems.年龄相关性黄斑变性的新型治疗方法：持续给药系统临床进展综述
Pharmaceutics. 2022 Jul 15;14(7):1473. doi: 10.3390/pharmaceutics14071473.
3
Prevalence of age-related macular degeneration among optometric telemedicine users in Spain: a retrospective nationwide population-based study.西班牙视光远程医疗用户中与年龄相关的黄斑变性患病率：一项回顾性全国基于人群的研究。
Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1993-2003. doi: 10.1007/s00417-021-05093-4. Epub 2021 Feb 12.
4
Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part I: Biomaterials-Based Drug Delivery Devices.用于年龄相关性黄斑变性的生物技术和基于生物材料的治疗策略。第一部分：基于生物材料的药物递送装置。
Front Bioeng Biotechnol. 2020 Nov 3;8:549089. doi: 10.3389/fbioe.2020.549089. eCollection 2020.
5
Oxidative stress, innate immunity, and age-related macular degeneration.氧化应激、先天免疫与年龄相关性黄斑变性
AIMS Mol Sci. 2016;3(2):196-221. doi: 10.3934/molsci.2016.2.196. Epub 2016 May 11.
本文引用的文献
1
Dual Association of beta-carotene with risk of tobacco-related cancers in a cohort of French women.在一组法国女性队列中，β-胡萝卜素与烟草相关癌症风险的双重关联。
J Natl Cancer Inst. 2005 Sep 21;97(18):1338-44. doi: 10.1093/jnci/dji276.
2
Smoking and age-related macular degeneration: a review of association.吸烟与年龄相关性黄斑变性：关联综述
Eye (Lond). 2005 Sep;19(9):935-44. doi: 10.1038/sj.eye.6701978.
3
Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.年龄相关性黄斑变性的进展：C反应蛋白、白细胞介素6及其他心血管生物标志物的前瞻性评估
Arch Ophthalmol. 2005 Jun;123(6):774-82. doi: 10.1001/archopht.123.6.774.
4
Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy.炎症、内皮功能障碍及年龄相关性黄斑病变的全身标志物。
Am J Ophthalmol. 2005 Jul;140(1):35-44. doi: 10.1016/j.ajo.2005.01.051.
5
Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration.肺炎衣原体感染与年龄相关性黄斑变性的进展
Am J Epidemiol. 2005 Jun 1;161(11):1013-9. doi: 10.1093/aje/kwi130.
6
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.补体调节基因因子H（HF1/CFH）中的一种常见单倍型使个体易患年龄相关性黄斑变性。
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32. doi: 10.1073/pnas.0501536102. Epub 2005 May 3.
7
Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment.
Surv Ophthalmol. 2005 May-Jun;50(3):263-73. doi: 10.1016/j.survophthal.2005.02.007.
8
The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences.美国年龄相关性黄斑变性的双生子研究：遗传和环境影响的相对作用。
Arch Ophthalmol. 2005 Mar;123(3):321-7. doi: 10.1001/archopht.123.3.321.
9
Complement factor H polymorphism in age-related macular degeneration.年龄相关性黄斑变性中的补体因子H多态性
Science. 2005 Apr 15;308(5720):385-9. doi: 10.1126/science.1109557. Epub 2005 Mar 10.
10
Complement factor H polymorphism and age-related macular degeneration.补体因子H基因多态性与年龄相关性黄斑变性
Science. 2005 Apr 15;308(5720):421-4. doi: 10.1126/science.1110189. Epub 2005 Mar 10.
Zotero 插件